Literature DB >> 27511346

Impact of antimicrobial drug restrictions on doctors' behaviors.

Oğuz Karabay1, Salih Hoşoğlu2, Ertuğrul Güçlü1, Şerife Akalin3, Fatma Aybala Altay4, Emsal Aydin5, Bahadır Ceylan6, Aygül Çelik7, İlhami Çelik8, Tuna Demirdal9, Keziban Demirli10, Nurettin Erben11, Ünal Erkorkmaz12, Serpil Erol13, Ömer Evirgen14, İbak Gönen15, Ayşe Ebru Güner16, Tümer Güven17, Ayten Kadanali18, Mücahide Esra Koçoğlu19, Ömer Faruk Kökoğlu14, Abdulkadir Küçükbayrak20, Fatma Sargin21, Mahmut Sünnetçioğlu22, Şebnem Şenol23, Meltem İşikgöz Taşbakan24, Recep Tekin2, Vedat Turhan25, Gürdal Yilmaz26, Behiye Dede18.   

Abstract

BACKGROUND/AIM: Broad-spectrum antibiotics have become available for use only with the approval of infectious disease specialists (IDSs) since 2003 in Turkey. This study aimed to analyze the tendencies of doctors who are not disease specialists (non-IDSs) towards the restriction of antibiotics.
MATERIALS AND METHODS: A questionnaire form was prepared, which included a total of 22 questions about the impact of antibiotic restriction (AR) policy, the role of IDSs in the restriction, and the perception of this change in antibiotic consumption. The questionnaire was completed by each participating physician.
RESULTS: A total of 1906 specialists from 20 cities in Turkey participated in the study. Of those who participated, 1271 (67.5%) had ≤5 years of occupational experience (junior specialists = JSs) and 942 (49.4%) of them were physicians. Specialists having >5 years of occupational experience in their branch expressed that they followed the antibiotic guidelines more strictly than the JSs (P < 0.05) and 755 of physicians (88%) and 720 of surgeons (84.6%) thought that the AR policy was necessary and useful (P < 0.05).
CONCLUSION: This study indicated that the AR policy was supported by most of the specialists. Physicians supported this restriction policy more so than surgeons did.

Entities:  

Keywords:  Antibiotic policy; antibiotic restriction; antibiotic usage; budget execution instructions; specialist

Mesh:

Substances:

Year:  2016        PMID: 27511346     DOI: 10.3906/sag-1405-26

Source DB:  PubMed          Journal:  Turk J Med Sci        ISSN: 1300-0144            Impact factor:   0.973


  1 in total

1.  Promoting rational antibiotic use in Turkey and among Turkish migrants in Europe - implications of a qualitative study in four countries.

Authors:  R Westerling; A Daryani; O Gershuni; K Czabanowska; H Brand; F Erdsiek; T Aksakal; S Uner; O Karadag Caman; H Ozcebe; P Brzoska
Journal:  Global Health       Date:  2020-11-11       Impact factor: 4.185

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.